In urothelial carcinoma, major immune effectors include CD4+ T helper cells, cytotoxic CD8+ T lymphocytes (CTLs), dendritic cells (DCs), tumor-associated macrophages (TAMs), and myeloid-derived suppressor cells (MDSCs) (13). This evidence concerns the gene CD8A and neoplasm.